End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.

@article{Mallett2014EndstageKD,
  title={End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.},
  author={Andrew J Mallett and Wen Tang and Philip Andrew Clayton and Sarah A. Stevenson and Stephen McDonald and Carmel Mary Hawley and Sunil V. Badve and Neil C Boudville and Fiona G. Brown and Scott Bryan Campbell and David W Johnson},
  journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
  year={2014},
  volume={29 12},
  pages={2277-86}
}
BACKGROUND Alport syndrome is a rare inheritable renal disease. Clinical outcomes for patients progressing to end-stage kidney disease (ESKD) are not well described. METHODS This study aimed to investigate the characteristics and clinical outcomes of patients from Australia and New Zealand commencing renal replacement therapy (RRT) for ESKD due to Alport syndrome between 1965 and 1995 (early cohort) and between 1996 and 2010 (contemporary cohort) compared with propensity score-matched, RRT… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 58 references

a review

  • KR Furaz-Czerpak, G Fernandez-Juarez, dialysis Moreno-de la Higuera MA et al. Pregnancy in women chronic
  • Nefrologia 2012; 32: 287–294 Received for…
  • 2014
1 Excerpt

Similar Papers

Loading similar papers…